RT Journal Article
T1 Clinical practice guidelines with recommendations for peripartum depression: A European systematic review.
A1 Motrico, Emma
A1 Moreno-Peral, Patricia
A1 Uriko, Kristiina
A1 Hancheva, Camellia
A1 Brekalo, Maja
A1 Ajaz, Erilda
A1 Apter, Gisele
A1 Bramante, Alessandra
A1 Conejo-Cerón, Sonia
A1 Christoforou, Andri
A1 Dikmen-Yildiz, Pelin
A1 Evagorou, Olympia
A1 Fonseca, Ana
A1 Lupattelli, Angela
A1 Radoš, Sandra Nakić
A1 Al Maach, Nadia
A1 Rodriguez-Muñoz, María F
A1 Žutić, Maja
A1 Lambregtse-van den Berg, Mijke P
K1 clinical practice guidelines
K1 depression
K1 perinatal
K1 peripartum
K1 systematic review
AB This study aims to systematically review all Clinical Practice Guidelines (CPGs) with recommendations for peripartum depression in European countries. A systematic review according to the PRISMA statement was conducted. CPGs focussing on peripartum depression or with at least one specific recommendation for peripartum depression from European countries were selected. Searching was conducted in electronic databases (MEDLINE and PsycINFO), and by contacting professional societies and international experts until November 24th, 2021. Characteristics of the included CPGs and their recommendations were extracted. A methodological quality assessment was conducted using the AGREE-II tool. A total of 239 records were identified after duplicate removal. Of these, 54 were examined for full-text inspection. The final selection yielded 14 CPGs from 11 European countries in 10 languages. Of them, 11 provided recommendations on pharmacological treatments, 10 on psychological treatment (e.g., cognitive-behavioural therapy), 10 on screening, 8 on diagnosis, 6 on other treatments (e.g., physical exercise), 5 on prevention, and 5 other recommendations (e.g., provide information). Regarding the overall methodological quality, only five (35.7%) guidelines were rated as of adequate quality, reaching a score ≥ 70% in the overall assessment of the AGREE-II instrument. Of the six AGREE-II domains, applicability scored the lowest and clarity of presentation scored the highest. The absence of CPGs in most European countries, the discrepancy in recommendations and the low methodological quality of the guidelines may lead to disparities and inequalities in peripartum depression management in Europe. The COST Action Riseup-PPD highlights key considerations for future guideline developers.
YR 2022
FD 2022-08-24
LK http://hdl.handle.net/10668/19884
UL http://hdl.handle.net/10668/19884
LA en
DS RISalud
RD Apr 9, 2025